Wuxi Biologics Cay New(WXIBF)
OTC US

Today's Change
Delayed Last Update
Day Low4.6800
Day High4.8000
Open:4.7500
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
WuXi Biologics Wins Full Shareholder Backing at 2026 AGM
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Wuxi Biologics (Cayman) (OtherWXIBF)
Wuxi Biologics Grants Time-Based Restricted Shares to 21 Employees
Guotai Haitong Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Analysts Are Bullish on Top Healthcare Stocks: Autolus Therapeutics (AUTL), Wuxi Biologics (Cayman) (WXIBF)
CICC Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
WuXi Biologics Schedules 2026 Business Update Calls for Investors
Analysts Offer Insights on Healthcare Companies: CSPC Pharmaceutical Group (OtherCHJTF) and Wuxi Biologics (Cayman) (OtherWXIBF)
UBS Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
WuXi Biologics Launches US$400 Million Share Buyback Plan
WuXi Biologics Sets 2026 AGM to Vote on Board, Auditors and New Share Mandate
Morgan Stanley Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Citi Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Alkermes (ALKS)
Guotai Haitong Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
CLSA Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Daiwa Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from UOB Kay Hian
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from CICC

Profile